{"id":24901,"date":"2022-10-06T12:00:00","date_gmt":"2022-10-06T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/"},"modified":"2022-10-06T12:00:00","modified_gmt":"2022-10-06T12:00:00","slug":"amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/","title":{"rendered":"Am\u00e9lioration de la coordination des soins dans l&#8217;inflammation de type 2"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1938 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>L&#8217;asthme, la rhinosinusite chronique avec polypes nasaux ou RSCaN et la dermatite atopique sont trois affections chroniques qui coexistent souvent chez les patients. Elles peuvent provoquer une multitude de sympt\u00f4mes allant de l\u00e9gers \u00e0 s\u00e9v\u00e8res. Au mieux, elles sont irritantes. Au pire, elles affectent profond\u00e9ment la qualit\u00e9 de vie des patients. Ces trois affections chroniques sont li\u00e9es par une pathogen\u00e8se commune appel\u00e9e inflammation de type 2.    <\/p>\n<p>Qu&#8217;est-ce que c&#8217;est ? Pourquoi est-ce pertinent ? Que savons-nous \u00e0 ce sujet ? Et comment am\u00e9liorer la vie de ces patients ?   <\/p>\n<ul>\n<li>Partie 1 : <a href=\"https:\/\/youtu.be\/9mS2cp3Ar8A\" target=\"_blank\" rel=\"noopener\">Qu&#8217;est-ce que l&#8217;inflammation de type 2 ?<\/a><\/li>\n<li>Partie 2 : <a href=\"https:\/\/youtu.be\/06pcLM6vbw0\" target=\"_blank\" rel=\"noopener\">Quelles sont les lacunes actuelles en mati\u00e8re de soins ?<\/a><\/li>\n<li>Partie 3 : <a href=\"https:\/\/youtu.be\/JIYC-jXkDos\" target=\"_blank\" rel=\"noopener\">Ambitions pour am\u00e9liorer les soins interdisciplinaires<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1939 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/oJT-SDsuiw4?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1946 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<h3 class=\"paragraph__title\">Ce forum d&#8217;innovation est soutenu par :<\/h3>\n<div class=\"text__text text text--paragraph\">\n<p><a href=\"https:\/\/www.sanofi.com\/en\/your-health\/specialty-care\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"align-left\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Sanofi-Regeneron_0.png\" alt=\"Sanofi Regeneron\" width=\"258\" height=\"172\" data-entity-type=\"file\" data-entity-uuid=\"e6811aeb-3761-40dc-b6ff-ab2d1131aacf\"><\/a><a href=\"https:\/\/www.gsk.com\/en-gb\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"align-left\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/GSK_2.png\" alt=\"GSK\" width=\"262\" height=\"174\" data-entity-type=\"file\" data-entity-uuid=\"12cdb561-4f1a-4b39-876a-95b461050fd5\"><\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;asthme, la rhinosinusite chronique avec polypes nasaux ou RSCaN et la dermatite atopique sont trois affections chroniques qui coexistent souvent chez les patients. Elles peuvent provoquer une multitude de sympt\u00f4mes allant de l\u00e9gers \u00e0 s\u00e9v\u00e8res. Au mieux, elles sont irritantes. Au pire, elles affectent profond\u00e9ment la qualit\u00e9 de vie des patients. Ces trois affections chroniques sont li\u00e9es par une pathogen\u00e8se commune appel\u00e9e inflammation de type 2. Qu&#8217;est-ce que c&#8217;est ? Pourquoi est-ce pertinent ? Que savons-nous \u00e0 ce sujet ? Et comment am\u00e9liorer la vie de ces patients ? Partie 1 : Qu&#8217;est-ce que l&#8217;inflammation de type 2 ? Partie 2 : Quelles sont les lacunes actuelles en mati\u00e8re de soins ? Partie 3 : Ambitions pour am\u00e9liorer les soins interdisciplinaires Ce forum d&#8217;innovation est soutenu par :<\/p>\n","protected":false},"author":1,"featured_media":24920,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[254],"tags":[191,255,256],"class_list":["post-24901","news","type-news","status-publish","has-post-thumbnail","hentry","category-debats-du-forum-dinnovation","tag-debats","tag-forum-de-linnovation","tag-inflammation-de-type-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Am\u00e9lioration de la coordination des soins dans l&#039;inflammation de type 2 - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Am\u00e9lioration de la coordination des soins dans l&#039;inflammation de type 2\" \/>\n<meta property=\"og:description\" content=\"L&#8217;asthme, la rhinosinusite chronique avec polypes nasaux ou RSCaN et la dermatite atopique sont trois affections chroniques qui coexistent souvent chez les patients. Elles peuvent provoquer une multitude de sympt\u00f4mes allant de l\u00e9gers \u00e0 s\u00e9v\u00e8res. Au mieux, elles sont irritantes. Au pire, elles affectent profond\u00e9ment la qualit\u00e9 de vie des patients. Ces trois affections chroniques sont li\u00e9es par une pathogen\u00e8se commune appel\u00e9e inflammation de type 2. Qu&#8217;est-ce que c&#8217;est ? Pourquoi est-ce pertinent ? Que savons-nous \u00e0 ce sujet ? Et comment am\u00e9liorer la vie de ces patients ? Partie 1 : Qu&#8217;est-ce que l&#8217;inflammation de type 2 ? Partie 2 : Quelles sont les lacunes actuelles en mati\u00e8re de soins ? Partie 3 : Ambitions pour am\u00e9liorer les soins interdisciplinaires Ce forum d&#8217;innovation est soutenu par :\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Sanofi-Regeneron_0.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\\\/\",\"name\":\"Am\u00e9lioration de la coordination des soins dans l'inflammation de type 2 - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png\",\"datePublished\":\"2022-10-06T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png\",\"width\":427,\"height\":280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Am\u00e9lioration de la coordination des soins dans l&#8217;inflammation de type 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Am\u00e9lioration de la coordination des soins dans l'inflammation de type 2 - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Am\u00e9lioration de la coordination des soins dans l'inflammation de type 2","og_description":"L&#8217;asthme, la rhinosinusite chronique avec polypes nasaux ou RSCaN et la dermatite atopique sont trois affections chroniques qui coexistent souvent chez les patients. Elles peuvent provoquer une multitude de sympt\u00f4mes allant de l\u00e9gers \u00e0 s\u00e9v\u00e8res. Au mieux, elles sont irritantes. Au pire, elles affectent profond\u00e9ment la qualit\u00e9 de vie des patients. Ces trois affections chroniques sont li\u00e9es par une pathogen\u00e8se commune appel\u00e9e inflammation de type 2. Qu&#8217;est-ce que c&#8217;est ? Pourquoi est-ce pertinent ? Que savons-nous \u00e0 ce sujet ? Et comment am\u00e9liorer la vie de ces patients ? Partie 1 : Qu&#8217;est-ce que l&#8217;inflammation de type 2 ? Partie 2 : Quelles sont les lacunes actuelles en mati\u00e8re de soins ? Partie 3 : Ambitions pour am\u00e9liorer les soins interdisciplinaires Ce forum d&#8217;innovation est soutenu par :","og_url":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","og_image":[{"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Sanofi-Regeneron_0.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/","url":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/","name":"Am\u00e9lioration de la coordination des soins dans l'inflammation de type 2 - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png","datePublished":"2022-10-06T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Innovation20Forum20-20Improved20Coordination20of20Care20in20Type20220Inflammation20Teaser.png","width":427,"height":280},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/fr\/news\/amelioration-de-la-coordination-des-soins-dans-linflammation-de-type-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/fr\/news\/"},{"@type":"ListItem","position":3,"name":"Am\u00e9lioration de la coordination des soins dans l&#8217;inflammation de type 2"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/fr\/#website","url":"https:\/\/www.euforea.org\/fr\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/fr\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/24901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=24901"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/24901\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/24920"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=24901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=24901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=24901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}